Cargando…
Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels
Inflammatory bowel disease (IBD), one kind of intestinal chronic inflammatory disease, is characterized by colonic epithelial barrier injury, overproduction of proinflammatory cytokines, and fewer short-chain fatty acids (SCFAs). The present study is aimed at testing the hypothesis that resistant ma...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519446/ https://www.ncbi.nlm.nih.gov/pubmed/33015180 http://dx.doi.org/10.1155/2020/7694734 |
_version_ | 1783587573055094784 |
---|---|
author | Wang, Shilan Zhang, Shiyi Huang, Shimeng Wu, Zhenhua Pang, Jiaman Wu, Yujun Wang, Junjun Han, Dandan |
author_facet | Wang, Shilan Zhang, Shiyi Huang, Shimeng Wu, Zhenhua Pang, Jiaman Wu, Yujun Wang, Junjun Han, Dandan |
author_sort | Wang, Shilan |
collection | PubMed |
description | Inflammatory bowel disease (IBD), one kind of intestinal chronic inflammatory disease, is characterized by colonic epithelial barrier injury, overproduction of proinflammatory cytokines, and fewer short-chain fatty acids (SCFAs). The present study is aimed at testing the hypothesis that resistant maltodextrin (RM), a soluble dietary fiber produced by starch debranching, alleviated dextran sulfate sodium- (DSS-) induced colitis in mice. Female C57BL/6 mice with or without oral administration of 50 mg/kg RM for 19 days were challenged with 3% DSS in drinking water to induce colitis (from day 14 to day 19). Although RM could not reverse DSS-induced weight loss or colon shortening, it reduced inflammatory cell infiltration and epithelial damage in colon tissue, as well as the transfer of intestinal permeability indicators including serum diamine oxidase (DAO) and D-lactic acid (D-LA). ELISA analysis indicated that RM significantly suppressed the increase of Th1 cytokines induced by DSS in the colon such as tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). The levels of proinflammatory cytokines interleukin-1β (IL-1β), IL-17, and IL-8 in the DSS group were significantly higher than those in the control group and RM group, but no significant difference was observed in the RM-DSS group compared with the RM group. Interestingly, IL-10 levels of the DSS group were significantly higher than those of the other groups. With respect to SCFAs, DSS administration significantly decreased the concentration of faecal butyric acid while the RM-DSS group showed a tendency to increase (P = 0.08). In general, RM alleviated dextran sulfate sodium-induced intestinal inflammation through increasing the level of butyric acid and subsequently inhibiting the expression of proinflammatory cytokines. |
format | Online Article Text |
id | pubmed-7519446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-75194462020-10-02 Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels Wang, Shilan Zhang, Shiyi Huang, Shimeng Wu, Zhenhua Pang, Jiaman Wu, Yujun Wang, Junjun Han, Dandan Biomed Res Int Research Article Inflammatory bowel disease (IBD), one kind of intestinal chronic inflammatory disease, is characterized by colonic epithelial barrier injury, overproduction of proinflammatory cytokines, and fewer short-chain fatty acids (SCFAs). The present study is aimed at testing the hypothesis that resistant maltodextrin (RM), a soluble dietary fiber produced by starch debranching, alleviated dextran sulfate sodium- (DSS-) induced colitis in mice. Female C57BL/6 mice with or without oral administration of 50 mg/kg RM for 19 days were challenged with 3% DSS in drinking water to induce colitis (from day 14 to day 19). Although RM could not reverse DSS-induced weight loss or colon shortening, it reduced inflammatory cell infiltration and epithelial damage in colon tissue, as well as the transfer of intestinal permeability indicators including serum diamine oxidase (DAO) and D-lactic acid (D-LA). ELISA analysis indicated that RM significantly suppressed the increase of Th1 cytokines induced by DSS in the colon such as tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). The levels of proinflammatory cytokines interleukin-1β (IL-1β), IL-17, and IL-8 in the DSS group were significantly higher than those in the control group and RM group, but no significant difference was observed in the RM-DSS group compared with the RM group. Interestingly, IL-10 levels of the DSS group were significantly higher than those of the other groups. With respect to SCFAs, DSS administration significantly decreased the concentration of faecal butyric acid while the RM-DSS group showed a tendency to increase (P = 0.08). In general, RM alleviated dextran sulfate sodium-induced intestinal inflammation through increasing the level of butyric acid and subsequently inhibiting the expression of proinflammatory cytokines. Hindawi 2020-09-16 /pmc/articles/PMC7519446/ /pubmed/33015180 http://dx.doi.org/10.1155/2020/7694734 Text en Copyright © 2020 Shilan Wang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wang, Shilan Zhang, Shiyi Huang, Shimeng Wu, Zhenhua Pang, Jiaman Wu, Yujun Wang, Junjun Han, Dandan Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels |
title | Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels |
title_full | Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels |
title_fullStr | Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels |
title_full_unstemmed | Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels |
title_short | Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels |
title_sort | resistant maltodextrin alleviates dextran sulfate sodium-induced intestinal inflammatory injury by increasing butyric acid to inhibit proinflammatory cytokine levels |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519446/ https://www.ncbi.nlm.nih.gov/pubmed/33015180 http://dx.doi.org/10.1155/2020/7694734 |
work_keys_str_mv | AT wangshilan resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels AT zhangshiyi resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels AT huangshimeng resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels AT wuzhenhua resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels AT pangjiaman resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels AT wuyujun resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels AT wangjunjun resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels AT handandan resistantmaltodextrinalleviatesdextransulfatesodiuminducedintestinalinflammatoryinjurybyincreasingbutyricacidtoinhibitproinflammatorycytokinelevels |